ResearcherJena University HospitalNo recent work listed
Andreas Minh Luu
Matched on ORCID iD 0000-0001-8981-8973; OpenAlex author ID A5062384772. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper
Papers 7
- Long-term effects of total vs. partial pancreatectomy among patients with pancreatic cancer: a population-based study. Co-author DOI 10.21037/atm-22-2217↗
- Recurrence of Pancreatic Ductal Adenocarcinoma after Complete Histopathological Remission Caused by FOLFIRINOX. Last author DOI 10.1159/000509231↗
- Late recurrences of pancreatic cancer in patients with long-term survival after pancreaticoduodenectomy. Co-author DOI 10.21037/jgo-20-433↗
- Prognostic value and impact of cerebral metastases in pancreatic cancer. Co-author DOI 10.1080/00015458.2018.1549379↗
- Surprising Twist in the Plot - Sister Mary Joseph's Nodule of Pancreatic Cancer Mimicking Wound Infection after Umbilical Hernia Repair. Co-author DOI 10.1007/s12029-017-9975-0↗
- Pathologic Complete Response of Pancreatic Cancer following Neoadjuvant FOLFIRINOX Treatment in Hepatic Metastasized Pancreatic Cancer. Co-author DOI 10.1159/000497827↗
- FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer. Co-author DOI 10.21037/jgo.2018.01.07↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Waldemar H. Uhl · 6 shared papers, 2018–2021 · strength 0.74
- Paper Recurrence of Pancreatic Ductal Adenocarcinoma after Complete Histopathological Remission Caused by FOLFIRINOX. DOI 10.1159/000509231↗
- Paper Late recurrences of pancreatic cancer in patients with long-term survival after pancreaticoduodenectomy. DOI 10.21037/jgo-20-433↗
- Paper Prognostic value and impact of cerebral metastases in pancreatic cancer. DOI 10.1080/00015458.2018.1549379↗
- Chris Braumann · 6 shared papers, 2018–2021 · strength 0.74
- Paper Recurrence of Pancreatic Ductal Adenocarcinoma after Complete Histopathological Remission Caused by FOLFIRINOX. DOI 10.1159/000509231↗
- Paper Late recurrences of pancreatic cancer in patients with long-term survival after pancreaticoduodenectomy. DOI 10.21037/jgo-20-433↗
- Paper Prognostic value and impact of cerebral metastases in pancreatic cancer. DOI 10.1080/00015458.2018.1549379↗
- Philipp Höhn · 5 shared papers, 2018–2021 · strength 0.63
- Paper Recurrence of Pancreatic Ductal Adenocarcinoma after Complete Histopathological Remission Caused by FOLFIRINOX. DOI 10.1159/000509231↗
- Paper Late recurrences of pancreatic cancer in patients with long-term survival after pancreaticoduodenectomy. DOI 10.21037/jgo-20-433↗
- Paper Prognostic value and impact of cerebral metastases in pancreatic cancer. DOI 10.1080/00015458.2018.1549379↗
- Johanna B. Munding · 5 shared papers, 2018–2021 · strength 0.60
- Paper Recurrence of Pancreatic Ductal Adenocarcinoma after Complete Histopathological Remission Caused by FOLFIRINOX. DOI 10.1159/000509231↗
- Paper Prognostic value and impact of cerebral metastases in pancreatic cancer. DOI 10.1080/00015458.2018.1549379↗
- Paper Surprising Twist in the Plot - Sister Mary Joseph's Nodule of Pancreatic Cancer Mimicking Wound Infection after Umbilic… DOI 10.1007/s12029-017-9975-0↗
- Anke Reinacher‐Schick · 2 shared papers, 2018–2019 · strength 0.20
- Orlin Belyaev · 1 shared paper, 2021 · strength 0.15
- Yun Zheng · 1 shared paper, 2022 · strength 0.13
- Zhiwen Yang · 1 shared paper, 2022 · strength 0.13
- Qiang Tao · 1 shared paper, 2022 · strength 0.13
- Lingmin Jiang · 1 shared paper, 2022 · strength 0.13
- Yong Wang · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.